HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ken Hirata Selected Research

N- pip- phenylalanine- homophenylalanine- vinyl sulfone phenyl

1/2018Two key cathepsins, TgCPB and TgCPL, are targeted by the vinyl sulfone inhibitor K11777 in in vitro and in vivo models of toxoplasmosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ken Hirata Research Topics

Disease

5Amebiasis (Amoebiasis)
05/2016 - 01/2002
2Stomach Neoplasms (Stomach Cancer)
02/2021 - 08/2015
2COVID-19
01/2021 - 10/2020
2Infections
01/2020 - 01/2012
2Chagas Disease (American Trypanosomiasis)
01/2020 - 12/2017
2Hemorrhage
04/2013 - 01/2012
2Amebic Dysentery (Amoebic Dysentery)
06/2012 - 01/2012
2Myocardial Ischemia (Ischemic Heart Diseases)
07/2003 - 04/2002
1Fistula
02/2021
1Disease Progression
01/2020
1Acute Disease
01/2020
1Toxoplasmosis
01/2018
1Protozoan Infections
01/2018
1Parasitic Diseases (Parasitic Disease)
12/2017
1Parasitemia
12/2017
1Cerebral Infarction
08/2015
1Hematemesis
04/2013
1Melena
04/2013
1Anemia
04/2013
1Amebic Liver Abscess
06/2012
1Rheumatoid Arthritis
06/2012
1Muscle Cramp (Cramp)
01/2012
1Neoplasms (Cancer)
01/2012
1Ulcer
01/2012
1Inflammation (Inflammations)
06/2010
1Diabetes Mellitus
01/2003
1Ischemia
04/2002
1Infarction (Infarctions)
04/2002

Drug/Important Bio-Agent (IBA)

4Pharmaceutical PreparationsIBA
01/2020 - 06/2012
3Peptide Hydrolases (Proteases)FDA Link
01/2018 - 07/2007
3Cysteine Proteases (Cysteine Protease)IBA
01/2012 - 01/2002
2Cysteine Proteinase InhibitorsIBA
01/2021 - 10/2020
2benzonidazole (benznidazole)IBA
01/2020 - 12/2017
2divinyl sulfoneIBA
01/2018 - 06/2010
2EnzymesIBA
12/2017 - 06/2010
2Auranofin (Ridaura)FDA Link
05/2016 - 06/2012
2AnticoagulantsIBA
08/2015 - 01/2012
1posaconazoleFDA Link
01/2020
1N- pip- phenylalanine- homophenylalanine- vinyl sulfone phenylIBA
01/2018
1CathepsinsIBA
01/2018
1NifurtimoxIBA
12/2017
1SterolsIBA
12/2017
1GoldIBA
05/2016
12- hydroxylamino- 5- ethyl- 5- propylbarbituric acid (HB 2)IBA
04/2013
1Antimicrobial PeptidesIBA
01/2012
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2012
1CathelicidinsIBA
01/2012
1Streptozocin (Streptozotocin)FDA Link
01/2003
1salicylhydroxamic acid (SHAM)IBA
04/2002
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
04/2002

Therapy/Procedure

4Therapeutics
12/2017 - 04/2002
1Choledochostomy
02/2021
1Gastrectomy
02/2021
1Neoadjuvant Therapy
08/2015
1Aftercare (After-Treatment)
07/2003
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
07/2003
1Ligation
04/2002